Early findings suggest some women with low-risk DCIS may avoid immediate surgery, although investigators caution that longer ...

Active surveillance is gaining traction for women with low-risk DCIS, but key questions on patient selection and long-term safety remain.

By Dennis Thompson HealthDay ReporterTUESDAY, March 31, 2026 (HealthDay News) — A “watch and wait” approach might be best for ...

Thomas Jefferson University biostatistician Terry Hyslop designed a trial showing active monitoring to be as effective as ...

THOUSANDS of women with a common form of breast cancer may soon not need any treatment at all, scientists have suggested.

Large randomized trial makes case for non-inferiority versus surgery; smaller study falls ...

A diagnosis of ductal carcinoma in situ, or DCIS, often comes as a surprise during a routine mammogram. While the news is understandably taxing, it is important to remember that DCIS is a noninvasive, ...

Leesburg, VA, February 8, 2023—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ultrafast (UF) MRI provides beneficial information that can be used in ...

NB: This will be the subject of an embargoed virtual news briefing Dr Antonio Esgueva at 14.00 hrs CET on Tuesday 15 November. Barcelona, Spain: Using ultrasound to guide surgery for patients with ...

Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...